Fol. Biol. 2015, 61, 43-48
https://doi.org/10.14712/fb2015061010043
Association of MicroRNA-146a rs2910164 Gene Polymorphism with Metabolic Syndrome
References
1. 2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645.
< , K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P., Loria, C. M., Smith, S. C. Jr. (https://doi.org/10.1161/CIRCULATIONAHA.109.192644>
2. 2004) The functions of animal microRNAs. Nature 431, 350-355.
< , V. (https://doi.org/10.1038/nature02871>
3. 2000) Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 31, 1100-1107.
< , E., Fluiter, K., Iyer, A., Zurolo, E., Vreijling, J., van Vliet, E. A., Baayen, J. C., Gorter, J. A. (https://doi.org/10.1111/j.1460-9568.2010.07122.x>
4. 2012) Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS ONE 7, e34872.
< , D. V., Zaravinos, A., Ziros, P. G., Iskrenova, R. P., Psyrogiannis, A. I., Kyriazopoulou, V. E., Habeos, I. G. (https://doi.org/10.1371/journal.pone.0034872>
5. 2013) MicroRNA genetic variations: association with type 2 diabetes. Acta Diabetol. 50, 867-872.
< , C., Di Fusco, D., Cacciotti, L., Morganti, R., D’Amato, C., Greco, C., Rufini, S., Novelli, G., Sangiuolo, F., Spallone, V., Borgiani, P. (https://doi.org/10.1007/s00592-013-0469-7>
6. 2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-711.
< , K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T. H., Miano, J. M., Ivey, K. N., Srivastava, D. (https://doi.org/10.1038/nature08195>
7. 2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-κB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 285, 38951-38960.
< , J. G., Li, Y. Y., Zhao, Y., Bhattacharjee, S., Lukiw, W. J. (https://doi.org/10.1074/jbc.M110.178848>
8. 2005) The metabolic syndrome. Lancet 365, 1415-1428.
< , R. H., Grundy, S. M., Zimmet, P. Z. (https://doi.org/10.1016/S0140-6736(05)66378-7>
9. 1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502.
< , W. T., Levy, R. I., Fredrickson, D. S. (https://doi.org/10.1093/clinchem/18.6.499>
10. 2013) Association of estrogen receptor α gene polymorphisms with metabolic syndrome in Egyptian women. Metabolism 62, 1437-1442.
< , M. H., Mehanna, E. T., Mesbah, N. M., Abo-Elmatty, D. M. (https://doi.org/10.1016/j.metabol.2013.05.014>
11. 2014) Ethnic and gender susceptibility to metabolic risk. Metab. Syndr. Relat. Disord. 12, 110-116.
< , S. M., Neeland, I. J., Turer, A. T., Vega, G. L. (https://doi.org/10.1089/met.2013.0113>
12. 2012) Association of TNF-α promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF-α and leptin levels in Indian adult women. Cytokine 57, 32-36.
< , V., Gupta, A., Jafar, T., Gupta, V., Agrawal, S., Srivastava, N., Kumar, S., Singh, A. K., Natu, S. M., Agarwal, C. G., Agarwal, G. G. (https://doi.org/10.1016/j.cyto.2011.04.012>
13. 2006) The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97, 3A-11A.
< , S. M. (https://doi.org/10.1016/j.amjcard.2005.11.010>
14. 2012) Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J. Gastroenterol. 18, 2827-2831.
< , R., Kovarikova, A., Bienertova-Vasku, J., Sachlova, M., Redova, M., Vasku, A., Svoboda, M., Radova, L., Kiss, I., Vyzula, R., Slaby, O. (https://doi.org/10.3748/wjg.v18.i22.2827>
15. 2009) Role of adipocytederived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo. Am. J. Physiol. Endocrinol. Metab. 296, E1110-1119.
< , Z. H., Gu, D., Mazzone, T. (https://doi.org/10.1152/ajpendo.90964.2008>
16. 2012) Micro-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 7, e44789.
< , A., Zurolo, E., Prabowo, A., Fluiter, K., Spliet, W. G., van Rijen, P. C., Gorter, J. A., Aronica, E. (https://doi.org/10.1371/journal.pone.0044789>
17. 2008) Genetics of metabolic syndrome. Curr. Diab. Rep. 8, 141-148.
< , T., Lahiry, P., Pollex, R. L., Hegele, R. A. (https://doi.org/10.1007/s11892-008-0025-y>
18. 2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85, 2402-2410.
< , A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., Quon, M. J. (https://doi.org/10.1210/jcem.85.7.6661>
19. 2011) Clinical significance of miR-146a in gastric cancer cases. Clin. Cancer Res. 17, 4277-4284.
< , R., Mimori, K., Tanaka, K., Komune, S., Mori, M. (https://doi.org/10.1158/1078-0432.CCR-10-2866>
20. 2011) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 48, 61-69.
< , L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., Zhao, J., Zhao, L. (https://doi.org/10.1007/s00592-010-0226-0>
21. 2010) MicroRNA-146a and human disease. Scand. J. Immunol. 71, 227-231.
< , L., Chen, X. P., Li, Y. J. (https://doi.org/10.1111/j.1365-3083.2010.02383.x>
22. 2011) Upregulation of microRNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syn drome. J. Toxicol. Environ. Health A 74, 1460-1468.
< , W. J., Dua, P., Pogue, A. I., Eicken, C., Hill, J. M. (https://doi.org/10.1080/15287394.2011.618973>
23. 2013) Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS ONE 8, e79584.
< , X. P., Zhang, T., Peng, B., Yu, L., Jiang, D. K. (https://doi.org/10.1371/journal.pone.0079584>
24. 1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
< , D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, R. C. (https://doi.org/10.1007/BF00280883>
25. 2012) Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol. Carcinogen. 51, E65-E73.
, K. T., Kim, J. W., Jeon, Y. J., Jang, M. J., Chong, S. Y., Oh, D., Kim, N. K. (
26. 2013) MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age 35, 1157-1172.
< , F., Lazzarini, R., Recchioni, R., Marcheselli, F., Rippo, M. R., Di Nuzzo, S., Albertini, M. C., Graciotti, L., Babini, L., Mariotti, S., Spada, G., Abbatecola, A. M., Antonicelli, R., Franceschi, C., Procopio, A. D. (https://doi.org/10.1007/s11357-012-9440-8>
27. 2008) Rapid changes in microRNA-146a expression negatively regulate the IL-1β-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 180, 5689-5698.
< , M. M., Moschos, S. A., Williams, A. E., Shepherd, N. J., Larner-Svensson, H. M., Lindsay, M. A. (https://doi.org/10.4049/jimmunol.180.8.5689>
28. 2011) Genetic variants and the metabolic syndrome: a systematic review. Obes. Rev. 12, 952-967.
< , C. M., Boer, J. M., Reiling, E., Feskens, E. J. (https://doi.org/10.1111/j.1467-789X.2011.00907.x>
29. 2013) MicroRNAs in the atherosclerotic plaque. Clin. Chem. 59, 1708-1721.
< , E., Oksala, N., Lehtimäki, T. (https://doi.org/10.1373/clinchem.2013.204917>
30. 2008) The prevalence of metabolic syndrome among US women of childbearing age. Am. J. Public Health 98, 1122-1127.
< , R. G., Olden, K. (https://doi.org/10.2105/AJPH.2007.120055>
31. 2013) Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus. PLoS ONE 8, e73272.
< , Y., Bao, W., Shan, Z., Liu, J., Yu, X., Xia, S., Gao, H., Wang, X., Yao, P., Hu, F. B., Liu, L. (https://doi.org/10.1371/journal.pone.0073272>
32. 2012) MicroRNA-146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS ONE 7, e30832.
< , R., Gushue, S., Huzarewich, R. L., Manguiat, K., Medina, S., Roberston, C., Booth, S. A. (https://doi.org/10.1371/journal.pone.0030832>
33. 2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex. Neurosci. Lett. 459, 100-104.
< , P., Lukiw, W. J. (https://doi.org/10.1016/j.neulet.2009.04.052>
34. 2008) A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29, 1963-1966.
< , J., Ambrosone, C. B., DiCioccio, R. A., Odunsi, K., Lele, S. B., Zhao, H. (https://doi.org/10.1093/carcin/bgn172>
35. 2006) NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486.
< , K. D., Boldin, M. P., Chang, K. J., Baltimore, D. (https://doi.org/10.1073/pnas.0605298103>
36. 1997) Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J. 16, 7432-7443.
< , T., Yoshida, N., Kishimoto, T., Akira, S. (https://doi.org/10.1093/emboj/16.24.7432>
37. 2012) The ACE insertion/deletion polymorphism and its association with metabolic syndrome. Metabolism 61, 891-897.
< , B., Ruiter, R., Chen, J., Pan, H., Wang, Y., Mi, J. (https://doi.org/10.1016/j.metabol.2011.10.022>
38. 2014) A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat. Res. 761, 15-20.
< , X. D., Cho, M., Cai, X. P., Cheng, J., Jing, X., Cen, J. M., Liu, X., Yang, X. L., Suh, Y. (https://doi.org/10.1016/j.mrfmmm.2014.01.001>
39. 2011) Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS ONE 6, e20471.
< , W., Xu, J., Liu, S., Chen, B., Wang, X., Li, Y., Qian, Y., Zhao, W., Wu, J. (https://doi.org/10.1371/journal.pone.0020471>
40. 2011) Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol. Oncol. 122, 33-37.
< , C., Wang, M., Ding, B., Wang, W., Fu, S., Zhou, D., Zhang, Z., Han, S. (https://doi.org/10.1016/j.ygyno.2011.03.032>
41. 2010) Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J. Gastroenterol. 16, 3578-3583.
< , Y., Sun, Q. M., Liu, N. N., Dong, G. H., Chen, J., Yang, L., Wang, B. (https://doi.org/10.3748/wjg.v16.i28.3578>